AMRI buys production facility in India

US company Albany Molecular Research Inc has completed the purchase of FineKem Laboratories Pvt, a manufacturing facility located in Aurangabad, India, that will significantly accelerate AMRI's ability to make custom pilot scale intermediates in India, which is expected to commence in the second quarter of 2008.

Expanding on the company's acquisition of manufacturing facilities in Aurangabad and Navi Mumbai in July 2007, the addition of custom pilot scale manufacturing also complements AMRI's current chemical development process capabilities in Hyderabad, India. Also, it ensures the addition of another compound, isosorbide mononitrate, to AMRI's generics portfolio.

AMRI intends to implement upgrades over the next few months to bring the existing facilities into compliance with US Food and Drug Administration regulations for manufacturing clinical trial materials and commercial drug substances. Anticipated costs related to purchase and upgrades are not expected to be material to the US firm's results of operations or financial position.